The abstract submission site for the 9th annual Symposium on Advanced Wound Care (SAWC) Fall meeting (at Caesars Palace in Las Vegas, NV from October 20-22, 2017) is now open.
Abstract Presenter Guidelines
Please carefully review the abstract submission guidelines, as there have been important changes in the process.
FAILURE TO ADHERE TO THE GUIDELINES MAY RESULT IN AN AUTOMATIC DECLINE OF YOUR ABSTRACT.
The Symposium on Advanced Wound Care (SAWC) is committed to providing the highest level of clinical education and information for physicians, nurses, physical therapists, researchers, podiatrists and dietitians involved in wound healing or wound care issues.
Important Note: Previously presented abstracts will no longer be automatically accepted for presentation at the upcoming meeting. All abstracts must be submitted through the abstract submission site and undergo the review process to be considered for presentation at the upcoming meeting.
Abstract Content and Format
Please limit abstracts to a 250–300 word count; this does not include the title or the author block, which is entered in a different area of the submission system. Make sure your abstract does not include the author block or the title or it will not be reviewed. Additionally, please do not write your abstract all in capital letters or your submission will not be reviewed.
Abstracts are brief summaries of the overall goal of an offering and the specific ideas or concepts that will be presented, including outcomes and implications for practice. Abstracts essentially answer four questions:
- What was the problem?
- How did the author(s) solve it?
- What was discovered?
- What can be learned from the experience?
Tip: instead of stating that "results will be presented...," state the results.
- The abstract title should adequately convey the content of the abstract and must not contain product trade names. Product trade names must also not be included in the body of the abstract.
- If it is essential to the content of an abstract to mention a product trade name, discuss that product by its generic name followed by an asterisk or other appropriate mark (*, †, °), then list the trade name at the end of the abstract. For example:
Sample title: Bilayered Skin Substitute* and the Management of a Diabetic Foot Ulcer
Sample text: “…the practitioner then applied bilayered skin substitute* to the…”
Product notation: *Apligraf®, Organogenesis, Inc., Canton, Mass
- Please do not include images or tables with your submission. They will be deleted and not included in any materials sent to the judges.
- This is a blind review process so please make sure that neither author(s) name(s) nor facility affiliation(s) appear in the abstract body text. Additionally, please make sure to remove all patient identifying information including names, professions, and/or other personal attributes.
- Before submission, the abstract should be checked for accuracy and completeness.
- Submitted abstracts may only be edited after contacting firstname.lastname@example.org for permission.
Author and Affiliation Information
- The authors in the author list should be listed in the order that they should appear in publications if the abstract is selected for presentation.
- List the complete name including a full first name, middle initials, last name, and credentials for each author, as it should be listed in publications if the abstract is selected for presentation.
- Please do not include author institutions, or contact information in the author list, or body of the abstract. If you enter authors' institutions or contact information in the author list or abstract body, they will be removed.
- An author’s name may appear on multiple abstracts, but if possible they should appear exactly the same to assist with indexing of the abstracts.
- References are optional but encouraged. Please limit references to the 10 most pertinent citations.
- The abstract title should adequately convey the content of the abstract and must not contain product trade names. Abstracts without titles or titles that identify presenting institution, authors, or geographic area will be disqualified.
- Do not capitalize all letters in the title of the abstract. Capitalize the first letter of all major words in the title as well as prepositions, articles, and conjunctions of four letters or more.
- A clear communication of the clinical or laboratory research objective(s), study methods, and findings (interim or final) must be presented in the abstract.
- The case series or complex case study abstract must include pertinent details of the situations encountered, materials/technology utilized, response progression and outcomes achieved.
- The information/educational report must communicate the purpose of the project in a clear and logical progression, which will allow the audience to understand usage or potential application of this material.
- For all categories, the overall abstract subject matter is to be current and relevant to the SAWC Fall audience.
- Please proofread carefully for factual and spelling errors. If published, the abstract will appear exactly as the abstract was submitted.
- Please do not write your abstract all in capital letters.
- The abstract needs to be free of any patient identification information including names, professions, and/or other personal attributes.
All abstract communications (e.g., submission confirmation, notification of acceptance/rejection, poster set-up instructions/oral abstract session details, registration confirmation requests) will be sent to the primary contact. The designated primary contact may differ from the primary author of the abstract. In this case, the primary contact will be responsible for notifying all authors of important details and deadlines. Please save email@example.com to your address book so that you do not miss important correspondences. We are not responsible for any e-mails that are not received due to misspellings, defunct e-mail accounts, or e-mails blocked from firstname.lastname@example.org.
- To be accepted to present an oral or poster abstract during the 2017 SAWC Fall Symposium, each proposed presentation must be described in an abstract. Each abstract will be blind-reviewed by judges who are experts in the field.
- Please note: These abstracts are blind-reviewed by a panel of expert judges; however, they should not be considered “peer reviewed.” Please do not label them peer reviewed in any capacity during the symposium or other unrelated instances.
- Each abstract will be reviewed based on specific criteria for the category in which it is placed. Therefore, it is very important for the author to specify in which category the abstract should be entered. The 4 categories are: Clinical Research, Laboratory Research, Case Series/Study, and Information/Educational Report.
Specific Review Criteria by Category
- Are the objective(s) stated clearly?
- Are the materials and methods designed appropriately to answer the stated objective(s) (i.e., with correct procedures, appropriate statistical measures, and tools that have been tested for reliability and validity)?
- Are the findings stated clearly, with equal emphasis given to statistically significant and non-significant findings, as well as equally to the major objective(s)?
- Is the information current and are (potential) outcomes important and relevant to the target audience?
- Was your research submitted to an IRB for review? If so, give the IRB’s name.
A minimum of 3 patients is necessary (unless case is a multi-interventional or unique situation and/or a unique technology is being used). Case studies are appropriate for illustrating new uses of existing products, new products, adverse events, or unexpected results, which are unusual or have the potential to stimulate new research or thought.
- Is the case series description clear and reproducible?
- Is there a level of complexity for this case series?
- Is the case series utilizing a unique or new technology?
- Is the case series new and current?
This category may include descriptions of wound care programs, quality improvement projects, educational tools, classification systems, treatment modalities, or products.
- Is the project innovative, can it be broadly applied to other settings, and/or is it a new approach to looking at a problem? Are the primary aspects of the project, including background information, stated clearly in a logical progression, which allows the reader to understand usage or potential application?
- Are the project outcomes clearly stated and pertinent to this audience?
- Is the information current and relevant, and could it potentially impact other clinicians’ practice?
- Are the background information, objective(s), materials and methods stated clearly and of importance and interest to this audience?
- Is the study designed appropriately to answer the stated objective(s) (i.e., with correct procedures, appropriate statistical measures, and tools that have been tested for reliability and validity)?
- Are objective results stated clearly with equal emphasis given to statistically significant and non-significant results, as well as equally to the major objective(s)?
- Is the information current and are (potential) outcomes important and relevant to the target audience?
Oral Abstract Presentations
- Oral abstracts will be 12 minutes long, followed by a 3-minute question and answer period.
- Oral abstracts will be grouped into two 60-minute sessions.
Presentations selected for our oral abstract presentation will be notified individually. Oral abstract presenters are also invited to present their abstract, in poster form, during the poster session if they desire. Notification of the intent to also present a poster must be sent to email@example.com by the set deadline.
Poster Abstract Presentations
- Posters are typically displayed on 4' high x 8' wide bulletin boards. SAWC does not require your poster to be of specific dimensions.
- Push pins will be provided. If you need additional mounting supplies, please bring them with you.
- The distribution of product samples is prohibited.
- Handouts and business cards may be distributed. Audiovisual equipment will not be available for poster presentations.
Previously Presented/Published Information
Poster presentations that have been previously presented or published are eligible for submission as long as previous publication/presentation is noted upon submission. All abstracts must be submitted again for the upcoming SAWC meeting, as previously presented abstracts will not be carried over.
Certificate of Merit
All poster presenters will be awarded a Certificate of Merit giving recognition to their contribution to the advancement of the wound care field. An electronic copy of the certificate will be available for download after October 22. Hard copies will not be provided on-site.
Conversation with the Authors
Many attendees have expressed that they enjoy the opportunity to converse with poster authors. However, we also recognize that your time is valuable and attending all the poster sessions can be burdensome to your schedule. Therefore, we are requesting that all presenters be available to present their poster(s) during the SAWC Fall Poster Reception, held on Saturday, October 21, 2017 from 5:30 p.m.–6:15 p.m. You are, of course, more than welcome to be present at all poster sessions.
Scheduled Poster Sessions
Posters must be set up between 8:00 a.m. and 4:00 p.m. on Friday, October 20, 2017. Posters must be set up and ready no later than 4:00 p.m. Posters will remain up and available for viewing throughout the conference.
Posters are open from 8:00 a.m.– 4:00 p.m.
Poster presenters not required to be present.
The SAWC Fall Poster Reception is from 5:30 p.m.– 6:15 p.m.
Poster presenters should attend this entire event.
Posters must be dismantled between the hours of 6:30 p.m.–9:00 p.m. on Saturday, October 21, 2017, and 8:00 a.m.–10:00 a.m. on Sunday, October 22, 2017. Posters should not be removed prior to 6:30 p.m. on Saturday, October 21. Any materials left in the poster area after 10:00 a.m. on Sunday, October 22, 2017 will be discarded by event staff, so please take your poster down in time.
AAWC Research Poster Grand Rounds
The Association for the Advancement of Wound Care (AAWC) Research Poster Grand Rounds are walking sessions, where attendees assemble at one of several AAWC educational research posters, are given a brief lecture outlining the key points by one of the AAWC Research Committee members or a board member, and then escorted to view two to three specially selected and related posters which have been critiqued by AAWC’s Research Committee. Please consider submitting your wound research work for review and critique by the AAWC. Interested authors are required to submit their poster abstract by no later than six weeks prior to SAWC in order for the review to occur.
AAWC will directly notify the individual identified as the contact person in the abstract submission, via e-mail of acceptance, and this is what you can expect:
- The main contact person will be notified by e-mail and asked to send a ppt or pdf copy of their research poster to a member of the Research Task Force subcommittee for peer review and critique.
- The research poster critique is not linked in any way to the poster awards — that is handled by a different committee.
- The AAWC research poster critique process requires you to send a copy of your poster to a Research Task Force team member by a deadline date set a few weeks before the SAWC conference. This is to give adequate time for the peer review process.
- If we do not receive a copy of your poster by this date, we will not include it in our Research Poster Critique or consider it for inclusion into the Research Poster Walking Grand Rounds.
- If we receive your poster pdf by the deadline, members of our AAWC Research Task Force will review your poster following a research critique guide (a template is available online) and provide you with a written critique of your poster at the SAWC Conference.
- Your research poster will also be eligible for inclusion in a walking critique and review during SAWC Research Poster Walking Grand Rounds.
- During the Walking Grand Rounds, members of the AAWC Research Task Force will be walking with a group of conference attendees around the poster hall and reviewing selected posters, pointing out good examples of research poster compositions and some areas for improvement, if applicable.
This exercise is completely educational and meant to be positive and constructive. The research investigator or poster author does not have to prepare in any way, but it is helpful (not required) if they can stand by their poster during walking rounds in case attendees have questions.
The educational research posters provide information on how to evaluate and improve methodology of wound research conducted using: the pre-experimental design, static group comparisons or cross-sectional designs, one group pre-test/post-test design including longitudinal time series and panel designs, quasi-experimental designs including pre-test/post-test nonequivalent group design, time series design, non-equivalent before/after design, and information on how to present your clinical research/education in a poster presentation by providing examples of what not to present when developing an effective, methodologically rigorous poster for dissemination of your findings.
- After the Monday, June 26, 2017, 11:59 p.m. EST deadline, abstracts may not be revised in any way or resubmitted.
- Proofread abstracts carefully to avoid errors before submission.
- Accepted abstracts will be published as submitted.
Disposition/Notification of Acceptance
- Abstracts will be accepted on a competitive basis.
- The primary contact will be notified of acceptance or rejection via e-mail the week of July 17. A list of accepted abstracts can also be found on the SAWC Fall (http://www.sawcfall.com) website during this time. The acceptance/rejection notification e-mail will be sent to the main contact identified in the abstract submission. Please do not inquire about that status of your submission before the end of the week of July 18, as no further information will be available.
- Prior to the meeting, all information will be forwarded to the primary contact only and they are responsible for notifying all the other authors of upcoming details.
SAWC requires proof of pre-registration for all accepted poster presenters.
After registering, it is the designated primary contact’s responsibility to mark his/her intent to present through the abstract submissions site by providing the badge number of the registered representative. The badge number can be found on your registration confirmation.
FOLLOW THE INSTRUCTIONS BELOW
- Log into your profile at http://submissions.sawc.net/.
- Click the accept/decline link under the column “badge number” for your accepted abstract. See example below.
- Select the registered representative’s name.
- Enter the registered representative’s badge number.
- Click submit.
All accepted abstracts must be marked with intent to present and a valid Badge ID number by August 7.
Please note: Even though you may be registered for SAWC, intent to present must still be submitted. If the intent to present is not submitted by August 7, 2017, the accepted abstract will be withdrawn.
Please note: It is not required for the first author to attend the meeting. A co-author, or any representative familiar with the work of the accepted abstract, may register. Primary authors do not have to notify SAWC of the change in presenter or if an alternate presenter is selected to represent the accepted abstract.
Poster numbers will be assigned in early September and primary contacts will be notified via e-mail.
On rare occasions, presenters scheduled to present their poster fail to show up and have not notified SAWC of their change in plans. When presenters do not appear to present their poster, the planning efforts of the Abstract Committee in providing a quality program are diminished significantly, there are significant cost implications, and the audience is unnecessarily disappointed with empty poster boards. SAWC staff will audit all posters for no shows. SAWC will no longer consider future abstract contributions to the SAWC meetings by presenters who fail to appear.
Acceptance of the abstract by the review committee obligates the author to be present. If circumstances prevent attendance, the author must arrange for the poster to be presented by a substitute, preferably a co-author. If you wish to withdraw your abstract, you must submit your request in writing by August 7, 2017 to firstname.lastname@example.org including the abstract title and first author. Failure to comply will result in ineligibility for the future SAWC meetings abstract submission process as first author.
Expenses associated with the submission and presentation of an abstract are the responsibility of the presenter and may include hotel, travel, and meeting registration.
Below is a summative list of important deadlines and reminders.
Abstract Submissions Site Open: Monday, April 10, 2017
Abstract Submissions Site Closed: Monday, June 26, 2017, 11:59 p.m.
Acceptance/Decline Notifications: Week of July 17, 2017
Registration/Intent to Present Due: Monday, August 7, 2017
Future Abstract Submission Dates
The abstract submission site for the 31st annual SAWC Spring/WHS 2018 meeting at Charlotte Convention Center in Charlotte, NC, will open on Monday, October 23, 2017 and will close at 11:59 p.m. EST on Monday, December 4, 2017.
In order to better serve you, the SAWC Abstract Team has put together a list of frequently asked questions (FAQs) we are often asked by the abstract contacts/authors. Please review our FAQs and abstract guidelines before contacting the SAWC Abstract Team with questions. If there are questions not already answered in the guidelines or FAQs, please e-mail: email@example.com.